Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Denali Therapeutics (DNLI)
Technical Analysis Report for USA stock DNLI Denali Therapeutics. Dated: 09 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics then click here. or read Experts views on Denali Therapeutics or Forecast & share price targets of Denali Therapeutics
Denali Therapeutics Opened at 17.33 and Closed at: 17.07, which is 0% of previous session's close. It moved within a range of 17.03 and 17.71
The session was a Bearish session with an average volume of 516079, which is -77.69% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 16.71 and resistance for tomorrow is 17.39
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 16.83, 16.59 resistance for tomorrow's hourly charts is 17.51, 17.95
10 Day SMA for Denali Therapeutics (DNLI) is 16.7 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Denali Therapeutics (DNLI) is 16.92 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Denali Therapeutics (DNLI) is 17.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 16.17 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Denali Therapeutics is 15.12 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Denali Therapeutics is at 16.92 and 200 DMA is at 15.12, while 50 DMA and 100 DMA are at 17.28 and 16.17 respectively
Denali Therapeutics (DNLI) moving average of 20 SMA is at 16.92 and 20 EMA is at 17.04
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Fri Jan | 17.07 | 16.92 | 17.04 |
| 08 Thu Jan | 17.07 | 16.94 | 17.04 |
| 07 Wed Jan | 16.95 | 17.07 | 17.04 |
| 06 Tue Jan | 17.21 | 17.21 | 17.05 |
| 05 Mon Jan | 16.02 | 17.35 | 17.03 |
| 02 Fri Jan | 16.27 | 17.55 | 17.14 |
Denali Therapeutics (DNLI) moving average of 50 SMA is at 17.28 and 50 EMA is at 16.99
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Fri Jan | 17.07 | 17.28 | 16.99 |
| 08 Thu Jan | 17.07 | 17.28 | 16.99 |
| 07 Wed Jan | 16.95 | 17.26 | 16.99 |
| 06 Tue Jan | 17.21 | 17.24 | 16.99 |
| 05 Mon Jan | 16.02 | 17.21 | 16.98 |
| 02 Fri Jan | 16.27 | 17.21 | 17.02 |
Denali Therapeutics (DNLI) moving average of 100 SMA is at 16.17 and 100 EMA is at 16.51
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Fri Jan | 17.07 | 16.17 | 16.51 |
| 08 Thu Jan | 17.07 | 16.15 | 16.5 |
| 07 Wed Jan | 16.95 | 16.12 | 16.49 |
| 06 Tue Jan | 17.21 | 16.1 | 16.48 |
| 05 Mon Jan | 16.02 | 16.07 | 16.47 |
| 02 Fri Jan | 16.27 | 16.06 | 16.48 |
Denali Therapeutics (DNLI) moving average of 200 SMA is at 15.12 and 200 EMA is at 16.85
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Fri Jan | 17.07 | 15.12 | 16.85 |
| 08 Thu Jan | 17.07 | 15.11 | 16.85 |
| 07 Wed Jan | 16.95 | 15.09 | 16.85 |
| 06 Tue Jan | 17.21 | 15.08 | 16.85 |
| 05 Mon Jan | 16.02 | 15.07 | 16.85 |
| 02 Fri Jan | 16.27 | 15.06 | 16.86 |
Zimmer Biomet has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Zimmer Biomet, about 2.16% more returns!
Novo Nordisk has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 18.69% more returns!
Mednax Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Mednax Inc, about 2.77% more returns!
Cvs Health has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Cvs Health, about 1.07% more returns!
Denali Therapeutics has performed better than Civitas Solutions in short term. Holding Denali Therapeutics could be a better choice for now!
Brookdale Senior has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Brookdale Senior, about 9.25% more returns!
Vericel Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Vericel Corporation, about 4.86% more returns!
Sarepta Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 11.29% more returns!
Denali Therapeutics has performed better than Soleno Therapeutics in short term. Holding Denali Therapeutics could be a better choice for now!
Merit Medical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 1.56% more returns!
Mesoblast has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Mesoblast, about 15.64% more returns!
Irhythm Technologies has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Irhythm Technologies, about 7.84% more returns!
Denali Therapeutics has performed better than Harrow Health in short term. Holding Denali Therapeutics could be a better choice for now!
Denali Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Denali Therapeutics could be a better choice for now!
Denali Therapeutics has performed better than Celldex Therapeutics in short term. Holding Denali Therapeutics could be a better choice for now!
Amarin Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Amarin Corporation, about 10.98% more returns!
Amphastar Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 8.83% more returns!
Denali Therapeutics has performed better than Addus Homecare in short term. Holding Denali Therapeutics could be a better choice for now!
Acadia Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 2.1% more returns!
Denali Therapeutics Technical analysis of indicators
Price action analysis of Denali Therapeutics (DNLI) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Denali Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Denali Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Denali Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Denali Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Denali Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.73 and Denali Therapeutics DNLI stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Denali Therapeutics DNLI stock. Volume based technical analysis of Denali Therapeutics DNLI stock is negative.
Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And DNLI Experts View which covers a lot of information including buying and selling signals
DNLI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Denali Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


